GPNMB-PERIO StNCT07475013
Effects of Non-Surgical Periodontal Treatment on Inflammatory and Bone Markers in Periodontitis Patients
At risk: Primary completion moved 5 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Enrollment reopened Show 4 more changesShow less
- Eligibility criteria expanded, about 11 words
- Primary completion pushed from Sep 1, 2026 to Feb 1, 2027
- Study completion pushed from Dec 1, 2026 to Apr 1, 2027
- Site details revised
- Minor Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Study sites: 0 to 1
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (4)
Arms and interventions
Participants with Stage III Grade B/C periodontitis. At baseline, clinical periodontal measurements are recorded, and serum and gingival crevicular fluid samples are collected. All participants receive non-surgical periodontal therapy consisting of Scaling and Root Planing (SRP). Follow-up visits are conducted at 6 weeks and 3 months post-treatment for repeated clinical assessments and sample collection to evaluate changes in biochemical markers (GPNMB, TGF-β1, RANKL, and OPG).
Periodontally healthy individuals. Participants undergo a single clinical periodontal examination and provide serum and gingival crevicular fluid samples at the baseline visit. This group serves as a reference for baseline biochemical marker levels. No therapeutic intervention is performed.
Procedures: Scaling and Root Planing (SRP)
Sites
1 site in 1 country
- Sağlık Bilimleri Üniversitesi Gülhane Diş Hekimliği FakültesiAnkara, Turkey (Türkiye)